Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)8 -paclitaxel prodrug: In Vivo conversion and antitumor efficacy

Journal of Controlled Release : Official Journal of the Controlled Release Society
Yu Tong TamGlen S Kwon

Abstract

Poly(ethylene glycol)-block-poly(d,l-lactic acid) (PEG-b-PLA) micelles affect drug solubilization, and a paclitaxel (PTX) loaded-PEG-b-PLA micelle (PTX-PM) is approved for cancer treatment due to injection safety and dose escalation (Genexol-PM®) compared to Taxol®. However, PTX-PM is unstable in blood, has rapid clearance, and causes dose-limiting toxicity. We have synthesized a prodrug for PTX (7-OH), using oligo(lactic acid) as a novel pro-moiety (o(LA)8-PTX) specifically for PEG-b-PLA micelles, gaining higher loading and slower release of o(LA)8-PTX over PTX. Notably, o(LA)8-PTX prodrug converts into PTX by a backbiting reaction in vitro, without requiring esterases. We hypothesize that o(LA)8-PTX-loaded PEG-b-PLA micelles (o(LA)8-PTX-PM) has a lower Cmax and higher plasma AUC than PTX-PM for improved therapeutic effectiveness. In Sprague-Dawley rats at 10 mg/kg, compared to o(LA)8-PTX-PM (10% w/w loading) and PTX-PM (10%), o(LA)8-PTX-PM (50% w/w loading) produces a 2- and 3-fold higher plasma AUC0-24 of PTX, lactic acid-PTX, and o(LA)2-PTX (o(LA)0-2-PTX), respectively. For o(LA)8-PTX-PM at 10 and 50% w/w loading, PTX and lactic acid-PTX are major bioactive metabolites, respectively. Fast prodrug conversion of o(LA)8-PTX in...Continue Reading

References

Jul 11, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B WeissB Leyland-Jones
Aug 1, 1995·Current Biology : CB·I Arnal, R H Wade
Mar 3, 1993·Journal of the National Cancer Institute·W K MurphyM N Raber
Apr 1, 1997·Journal of Pharmaceutical Sciences·M RamaswamyK M Wasan
Jun 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A BookmanR F Ozols
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C KimM H Seo
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tae-You KimYung-Jue Bang
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kang Moo HuhKinam Park
Dec 21, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K L Hennenfent, R Govindan
Apr 28, 2006·Journal of Pharmaceutical Sciences·Bianca M Liederer, Ronald T Borchardt
Jun 28, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hui XiaoGeorge A Orr
Dec 16, 2006·Current Pharmaceutical Design·J LiuC Allen
Apr 19, 2008·The New England Journal of Medicine·Joseph A SparanoNancy E Davidson
Jul 11, 2008·Current Neuropharmacology·Charity D ScriptureAlex Sparreboom
May 3, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho-Chul ShinGlen S Kwon
Dec 25, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hyunah ChoGlen S Kwon
Apr 14, 2016·Nature Communications·Yiming ZhaoWillem J M Mulder

❮ Previous
Next ❯

Citations

Feb 25, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xue ChenYao Fu
Nov 10, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lauren ReppGlen S Kwon
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Meng ChengLiangxing Tu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.